Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Core Biogenesis has raised $10.5M in total funding. The most recent round was Series A. The last funding was announced in July 2022.
Core Biogenesis's investors include Plug and Play, Entrepreneurs First, European Innovation Council, XAnge, Blue Horizon Corporation.
Core Biogenesis is headquartered in Paris, France.
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Core Biogenesis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Core Biogenesis — Funding & Investors." VCBacked, July 28, 2022, https://www.vcbacked.co/company/core-biogenesis. Accessed July 20, 2026.
VCBacked. (2022). Core Biogenesis — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/core-biogenesis
{{cite web |title=Core Biogenesis — Funding & Investors |url=https://www.vcbacked.co/company/core-biogenesis |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated